Industry News
Biotechnology Industry News

Inclusion of women in stroke trials hasn’t changed in 30 years: study
Inclusion of women in stroke trials hasn't changed in 30 years: study klahucik Tue, 10/26/2021 - 11:15
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors ntaylor Tue, 10/26/2021 - 08:00
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects ntaylor Tue, 10/26/2021 - 07:20
UPDATE: Eli Lilly kick-starts speedy FDA review for Alzheimer’s hopeful donanemab—and a one-on-one test against Aduhelm
UPDATE: Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm badams Tue, 10/26/2021 - 06:59
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report arlene.weintraub Mon, 10/25/2021 - 10:53
Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful
Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful badams Mon, 10/25/2021 - 08:59
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession ntaylor Mon, 10/25/2021 - 08:26
EMA starts rolling review of Merck’s molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data
EMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data ntaylor Mon, 10/25/2021 - 07:41
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform badams Fri, 10/22/2021 - 07:28
Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue
Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue badams Fri, 10/22/2021 - 06:32
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising klahucik Thu, 10/21/2021 - 17:51
Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and a backer with intimate knowledge of its rival
Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival badams Thu, 10/21/2021 - 09:00
VCs back Leucid to trial CAR-T twist in ovarian cancer patients
VCs back Leucid to trial CAR-T twist in ovarian cancer patients ntaylor Thu, 10/21/2021 - 08:09
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA ntaylor Thu, 10/21/2021 - 06:12
FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test
FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test badams Wed, 10/20/2021 - 13:59
Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson’s
Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson's ntaylor Wed, 10/20/2021 - 08:43
Takeda crashes out of Wave discovery pact at cost of $23M
Takeda crashes out of Wave discovery pact at cost of $23M ntaylor Wed, 10/20/2021 - 07:51
Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR and other tools
Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR and other tools aliu Wed, 10/20/2021 - 06:20
Amid Amgen’s similar struggles, AstraZeneca slams the brakes on MCL-1 blood cancer drug
Amid Amgen's similar struggles, AstraZeneca slams the brakes on MCL-1 blood cancer drug badams Wed, 10/20/2021 - 06:11
Injured tumor cells activate immuno-oncology drugs to combat breast cancer and melanoma in mice
Injured tumor cells activate immuno-oncology drugs to combat breast cancer and melanoma in mice arlene.weintraub Tue, 10/19/2021 - 11:06

